Cargando…

Comparison of Subgenomic and Total RNA in SARS-CoV-2-Challenged Rhesus Macaques

Respiratory virus challenge studies involve administration of the challenge virus and sampling to assess for protection in the same anatomical locations. It can therefore be difficult to differentiate actively replicating virus from input challenge virus. For SARS-CoV-2, specific monitoring of activ...

Descripción completa

Detalles Bibliográficos
Autores principales: Dagotto, Gabriel, Mercado, Noe B., Martinez, David R., Hou, Yixuan J., Nkolola, Joseph P., Carnahan, Robert H., Crowe, James E., Baric, Ralph S., Barouch, Dan H.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society for Microbiology 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103707/
https://www.ncbi.nlm.nih.gov/pubmed/33472939
http://dx.doi.org/10.1128/JVI.02370-20
_version_ 1783689352837070848
author Dagotto, Gabriel
Mercado, Noe B.
Martinez, David R.
Hou, Yixuan J.
Nkolola, Joseph P.
Carnahan, Robert H.
Crowe, James E.
Baric, Ralph S.
Barouch, Dan H.
author_facet Dagotto, Gabriel
Mercado, Noe B.
Martinez, David R.
Hou, Yixuan J.
Nkolola, Joseph P.
Carnahan, Robert H.
Crowe, James E.
Baric, Ralph S.
Barouch, Dan H.
author_sort Dagotto, Gabriel
collection PubMed
description Respiratory virus challenge studies involve administration of the challenge virus and sampling to assess for protection in the same anatomical locations. It can therefore be difficult to differentiate actively replicating virus from input challenge virus. For SARS-CoV-2, specific monitoring of actively replicating virus is critical for investigating the protective and therapeutic efficacy of vaccines, monoclonal antibodies, and antiviral drugs. We adapted a SARS-CoV-2 subgenomic RNA (sgRNA) RT-PCR assay to differentiate productive infection from inactivated or neutralized virus. Subgenomic RNAs are generated after cell entry and are poorly incorporated into mature virions, and thus may provide a marker for actively replicating virus. We show envelope (E) sgRNA was degraded by RNase in infected cell lysates, while genomic RNA (gRNA) was protected, presumably due to packaging into virions. To investigate the capacity of the sgRNA assay to distinguish input challenge virus from actively replicating virus in vivo, we compared the E sgRNA assay to a standard nucleoprotein (N) or E total (both gRNA and sgRNA) RNA in convalescent rhesus macaques and in antibody-treated rhesus macaques after experimental SARS-CoV-2 challenge. In both studies, the E sgRNA assay was negative, suggesting protective efficacy, whereas the N and E total RNA assays remained positive. These data suggest the potential utility of sgRNA to monitor actively replicating virus in prophylactic and therapeutic SARS-CoV-2 studies. IMPORTANCE Developing therapeutic and prophylactic countermeasures for the SARS-CoV-2 virus is a public health priority. During challenge studies, respiratory viruses are delivered and sampled from the same anatomical location. It is therefore important to distinguish actively replicating virus from input challenge virus. The most common assay for detecting SARS-CoV-2 virus, reverse transcription PCR (RT-PCR) targeting nucleocapsid total RNA, cannot distinguish neutralized input virus from replicating virus. In this study, we assess SARS-CoV-2 subgenomic RNA as a potential measure of replicating virus in rhesus macaques.
format Online
Article
Text
id pubmed-8103707
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher American Society for Microbiology
record_format MEDLINE/PubMed
spelling pubmed-81037072021-05-07 Comparison of Subgenomic and Total RNA in SARS-CoV-2-Challenged Rhesus Macaques Dagotto, Gabriel Mercado, Noe B. Martinez, David R. Hou, Yixuan J. Nkolola, Joseph P. Carnahan, Robert H. Crowe, James E. Baric, Ralph S. Barouch, Dan H. J Virol Vaccines and Antiviral Agents Respiratory virus challenge studies involve administration of the challenge virus and sampling to assess for protection in the same anatomical locations. It can therefore be difficult to differentiate actively replicating virus from input challenge virus. For SARS-CoV-2, specific monitoring of actively replicating virus is critical for investigating the protective and therapeutic efficacy of vaccines, monoclonal antibodies, and antiviral drugs. We adapted a SARS-CoV-2 subgenomic RNA (sgRNA) RT-PCR assay to differentiate productive infection from inactivated or neutralized virus. Subgenomic RNAs are generated after cell entry and are poorly incorporated into mature virions, and thus may provide a marker for actively replicating virus. We show envelope (E) sgRNA was degraded by RNase in infected cell lysates, while genomic RNA (gRNA) was protected, presumably due to packaging into virions. To investigate the capacity of the sgRNA assay to distinguish input challenge virus from actively replicating virus in vivo, we compared the E sgRNA assay to a standard nucleoprotein (N) or E total (both gRNA and sgRNA) RNA in convalescent rhesus macaques and in antibody-treated rhesus macaques after experimental SARS-CoV-2 challenge. In both studies, the E sgRNA assay was negative, suggesting protective efficacy, whereas the N and E total RNA assays remained positive. These data suggest the potential utility of sgRNA to monitor actively replicating virus in prophylactic and therapeutic SARS-CoV-2 studies. IMPORTANCE Developing therapeutic and prophylactic countermeasures for the SARS-CoV-2 virus is a public health priority. During challenge studies, respiratory viruses are delivered and sampled from the same anatomical location. It is therefore important to distinguish actively replicating virus from input challenge virus. The most common assay for detecting SARS-CoV-2 virus, reverse transcription PCR (RT-PCR) targeting nucleocapsid total RNA, cannot distinguish neutralized input virus from replicating virus. In this study, we assess SARS-CoV-2 subgenomic RNA as a potential measure of replicating virus in rhesus macaques. American Society for Microbiology 2021-03-25 /pmc/articles/PMC8103707/ /pubmed/33472939 http://dx.doi.org/10.1128/JVI.02370-20 Text en Copyright © 2021 Dagotto et al. https://creativecommons.org/licenses/by/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution 4.0 International license (https://creativecommons.org/licenses/by/4.0/) . https://doi.org/10.1128/ASMCopyrightv2This article is made available via the PMC Open Access Subset for unrestricted noncommercial re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic.
spellingShingle Vaccines and Antiviral Agents
Dagotto, Gabriel
Mercado, Noe B.
Martinez, David R.
Hou, Yixuan J.
Nkolola, Joseph P.
Carnahan, Robert H.
Crowe, James E.
Baric, Ralph S.
Barouch, Dan H.
Comparison of Subgenomic and Total RNA in SARS-CoV-2-Challenged Rhesus Macaques
title Comparison of Subgenomic and Total RNA in SARS-CoV-2-Challenged Rhesus Macaques
title_full Comparison of Subgenomic and Total RNA in SARS-CoV-2-Challenged Rhesus Macaques
title_fullStr Comparison of Subgenomic and Total RNA in SARS-CoV-2-Challenged Rhesus Macaques
title_full_unstemmed Comparison of Subgenomic and Total RNA in SARS-CoV-2-Challenged Rhesus Macaques
title_short Comparison of Subgenomic and Total RNA in SARS-CoV-2-Challenged Rhesus Macaques
title_sort comparison of subgenomic and total rna in sars-cov-2-challenged rhesus macaques
topic Vaccines and Antiviral Agents
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8103707/
https://www.ncbi.nlm.nih.gov/pubmed/33472939
http://dx.doi.org/10.1128/JVI.02370-20
work_keys_str_mv AT dagottogabriel comparisonofsubgenomicandtotalrnainsarscov2challengedrhesusmacaques
AT mercadonoeb comparisonofsubgenomicandtotalrnainsarscov2challengedrhesusmacaques
AT martinezdavidr comparisonofsubgenomicandtotalrnainsarscov2challengedrhesusmacaques
AT houyixuanj comparisonofsubgenomicandtotalrnainsarscov2challengedrhesusmacaques
AT nkololajosephp comparisonofsubgenomicandtotalrnainsarscov2challengedrhesusmacaques
AT carnahanroberth comparisonofsubgenomicandtotalrnainsarscov2challengedrhesusmacaques
AT crowejamese comparisonofsubgenomicandtotalrnainsarscov2challengedrhesusmacaques
AT baricralphs comparisonofsubgenomicandtotalrnainsarscov2challengedrhesusmacaques
AT barouchdanh comparisonofsubgenomicandtotalrnainsarscov2challengedrhesusmacaques